- Home
- XBIT vs SRTS Comparison
XBIT vs SRTS Comparison
Compare XBIT & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- SRTS
- Stock Information
- Founded
- XBIT 2005
- SRTS 2010
- Country
- XBIT United States
- SRTS United States
- Employees
- XBIT N/A
- SRTS N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- SRTS Medical/Dental Instruments
- Sector
- XBIT Health Care
- SRTS Health Care
- Exchange
- XBIT Nasdaq
- SRTS Nasdaq
- Market Cap
- XBIT 86.3M
- SRTS 75.5M
- IPO Year
- XBIT 2015
- SRTS 2016
- Fundamental
- Price
- XBIT $2.71
- SRTS $3.14
- Analyst Decision
- XBIT
- SRTS Strong Buy
- Analyst Count
- XBIT 0
- SRTS 3
- Target Price
- XBIT N/A
- SRTS $8.00
- AVG Volume (30 Days)
- XBIT 52.7K
- SRTS 84.3K
- Earning Date
- XBIT 11-12-2025
- SRTS 11-13-2025
- Dividend Yield
- XBIT N/A
- SRTS N/A
- EPS Growth
- XBIT N/A
- SRTS N/A
- EPS
- XBIT N/A
- SRTS N/A
- Revenue
- XBIT N/A
- SRTS $37,564,000.00
- Revenue This Year
- XBIT N/A
- SRTS N/A
- Revenue Next Year
- XBIT N/A
- SRTS $33.38
- P/E Ratio
- XBIT N/A
- SRTS N/A
- Revenue Growth
- XBIT N/A
- SRTS 3.29
- 52 Week Low
- XBIT $2.50
- SRTS $3.03
- 52 Week High
- XBIT $8.32
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- XBIT 34.88
- SRTS 36.37
- Support Level
- XBIT $2.72
- SRTS $3.16
- Resistance Level
- XBIT $3.61
- SRTS $3.29
- Average True Range (ATR)
- XBIT 0.16
- SRTS 0.12
- MACD
- XBIT -0.05
- SRTS 0.05
- Stochastic Oscillator
- XBIT 2.25
- SRTS 13.32
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.